Alnylam Pharmaceuticals Inc. said Wednesday its stock will be halted on Nasdaq through the day as a regulatory advisory committee will meet to review its new...
Alnylam Pharmaceuticals Inc.
Amyloidosis. The treatment called onpattro, or patisiran, is approved in the U.S. and Canada for the treatment of the polyneuropathy of hereditary is a progressive, debilitating and fatal disease caused by misfolded transthyretin proteins, which accumulate as amyloid deposits in various parts of the body, including the nerves, heart and gastrointestinal tract. Patients can have polyneuropathy, cardiomyopathy, or both manifestations of the disease. There are two different forms of
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Crinetics Pharmaceuticals shares surge 65%, analysts raise price target after acromegaly treatment resultsShares of Crinetics Pharmaceuticals Inc. gained 65% premarket on Monday after the company announced positive results from a late-stage study of paltusotine,...
Leer más »
Madrigal Pharmaceuticals shares fall after new CEO namedShares of Madrigal Pharmaceuticals Inc. fell more than 7% premarket on Monday after the company appointed Bill Sibold, a former Sanofi executive, as its new...
Leer más »
Ford stock boosted by UBS upgrade, Nio shares drop on probe, and other stocks on the moveFord, General Motors, Apple and Rocket Pharmaceuticals are active.
Leer más »
FDA approves updated Covid vaccines from Pfizer and Moderna as hospitalizations riseThe Biden administration said it expects the new Pfizer and Moderna vaccines targeting the omicron variant XBB.1.5 to be available in mid-September.
Leer más »
FDA Approves Newest Covid-19 BoostersVaccine specialists say the updated shots should protect against strains now circulating. The boosters should be available within days..
Leer más »
FDA okays new coronavirus vaccine as respiratory illness season nearsThe covid vaccines are expected to be available later this week after the Centers for Disease Control and Prevention signs off.
Leer más »